Procedure
Skin-to-skin
Skin-to-skin is a medical procedure with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Detailed Status
Active, not recruiting1
Completed1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
active_not_recruiting133%
completed133%
terminated133%
Recent Activity
1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable
Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation
NCT02024854
terminatednot_applicable
Immediate Parent -Infant Skin-to-Skin Study (IPISTOSS)
NCT03521310
completednot_applicable
A Pilot Randomized Controlled Trial of the Effects of Daily Skin-to-skin Contact (PRCTS2S)
NCT04368767
Clinical Trials (3)
Showing 3 of 3 trials
NCT02024854Not Applicable
Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation
NCT03521310Not Applicable
Immediate Parent -Infant Skin-to-Skin Study (IPISTOSS)
NCT04368767Not Applicable
A Pilot Randomized Controlled Trial of the Effects of Daily Skin-to-skin Contact (PRCTS2S)
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3